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ABSTRACT 
Objective: Delayed heart rate (HR) recovery in the immediate post-exercise period has 
been linked to adverse cardiovascular prognosis. The after-effects of an acute bout of 
exercise on HR modulation in postmenopausal women and the influence of estrogen 
therapy are unknown.  Methods: In 13 sedentary postmenopausal women (PMW: 54±2 
years; mean ± SEM), we assessed heart rate variability (HRV), an index of HR 
modulation, and the influence of estrogen therapy on HRV.  HRV in the frequency 
domain was quantified during supine rest and again 60 minutes after treadmill exercise 
for 45 minutes at 60% VO2peak. PMW were studied before and after 4 weeks of oral 
estradiol. To obtain reference values for the after-effects of exercise on HRV in healthy 
young females, 14 premenopausal women (PreM) completed the identical exercise 
protocol.  Results: Compared with PreM, PMW demonstrated lower high frequency (HF; 
vagal modulation) and total HRV (P< 0.05) at rest. In PreM, all HRV values were similar 
before and after exercise. In contrast, in PMW after exercise, despite having identical HR 
to PreM, HF and total HRV were all lower (all P ≤ 0.01) compared with pre-exercise 
HRV values. Estrogen therapy had no effect on pre- or post-exercise values for HRV.  
Conclusions: When compared with PreM, PMW have identical HR but lower vagal HR 
modulation at rest and delayed HRV recovery after exercise. Estrogen does not restore 
baseline HRV or accelerate HRV recovery post-exercise, suggesting aging rather than 
estrogen deficiency per se may lower HRV in postmenopausal women.  
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INTRODUCTION 
Fluctuations in heart rate (HR) reflect autonomic modulation of sino-atrial discharge 1, 2. 
In cardiovascular disease diminished heart rate variability (HRV) usually reflects 
increased sympathetic and decreased vagal tonic HR modulation. These autonomic 
perturbations have been associated with increased risk for adverse cardiovascular events 
and mortality even in asymptomatic individuals 3, 4.  
Exercise has profound and complex effects on autonomic HR modulation 5. 
Importantly, these effects depend on the temporal relationship to exercise plus the 
cumulative effects of exercise training on autonomic tone. For example, increased cardiac 
sympathetic tone and coincident parasympathetic withdrawal occur during acute exercise 
5, 6. An increased risk of death during and immediately following exercise has been 
attributed in part to both the magnitude and subsequent rate of restoration of normal 
autonomic balance 7. In direct contrast to these acute effects of exercise, regular aerobic 
exercise training is cardioprotective, and associated independently with a reduction in 
cardiovascular events and total mortality 8.   These benefits include an increased 
predominance of parasympathetic heart rate modulation in the exercise trained vs. the un-
trained state 9, 10.   
Potentially adverse changes in neural modulation of HR have been shown to 
occur following both natural 11, 12 and surgical 13 menopause, thus suggesting that 
endogenous estrogen deficiency may be a factor contributing to a decrease in HRV 
following menopausal transition.  Regular exercise is recommended as a non-
pharmacological intervention to reduce cardiovascular risk and improve cardiovascular 
risk factor profile in postmenopausal women 14, 15. One mechanism contributing to the 
cardioprotective benefit of exercise in this population may be an enhancement of 
parasympathetic HR modulation in the physically trained state 16, 17.  
Several of the cardiovascular benefits associated with exercise training may be 
induced rapidly, possibly after a single bout of exercise 18. In this regard, we have 
demonstrated previously a reduction in blood pressure and an improvement in 
endothelial-dependent flow-mediated dilation in postmenopausal women when measured 
one hour following treadmill exercise for 45 minutes at 60% of peak oxygen 
consumption (VO2peak) 19, 20. To our knowledge, the pattern and rate of HRV recovery in 
healthy sedentary PMW woman after a single bout of sub-maximal aerobic exercise has 
not been reported, but may be of clinical relevance, given the contrasting immediate 
versus delayed effects of exercise on autonomic modulation.  Furthermore, whether HRV 
recovery after exercise in this population is influenced by treatment with estrogen is 
unknown. Thus, this study in sedentary postmenopausal women was designed to 
determine, using frequency domain HRV analysis:  1) the pattern and degree of recovery 
of tonic autonomic HR modulation measured 60 minutes after a single bout of sub-
maximal dynamic exercise of a type and intensity commonly prescribed to enhance 
cardiovascular health; 2) whether autonomic modulation following exercise is influenced 
by concurrent administration of oral estrogen. To characterize the after-effects of exercise 
on autonomic modulation in a comparator group of healthy younger estrogen-replete 
females, normotensive premenopausal women were submitted to the identical protocol. 
 
 
 
METHODS 
Participants: We have previously reported the relationship between estrogen therapy, 
blood pressure and vascular function both before and after an acute bout of dynamic 
exercise in these pre- and postmenopausal women 19, 20.  However, thus far we have not 
evaluated the effects of an acute bout of exercise on their HRV.  Postmenopausal women 
(n=13) were deemed healthy as determined by medical history, physical examination, and 
screening hematologic and biochemical testing performed before study entry. All were 
sedentary (no more than 2hrs of physical activity per week for at least the previous 6 
months), normotensive (seated clinic blood pressure [BP] of ≤140/90 mm Hg), non-
diabetic, non-smokers, and on no medications. To be eligible, participants reported at 
least 12 months of amenorrhea with the uterus intact or a previous hysterectomy. 
Biochemical evidence (serum follicle-stimulating hormone concentration [FSH] of ≥20 
IU/L) confirmed menopausal status. No subject received hormone replacement therapy 
for at least 2 months before study entry.   
To obtain reference HRV values to compare with postmenopausal women, 14 
healthy premenopausal women were also investigated under identical experimental 
conditions. All premenopausal women described regular menstrual cycles, averaging 25 
to 35 days.  None were receiving any oral contraceptive formulations. Premenopausal 
women were studied during the follicular phase (estrogen relatively unopposed by 
progesterone) between days 5 to 13 of the menstrual cycle. Pregnancy was excluded by a 
negative β-human chorionic gonadotropin test. 
The protocol was approved by our institutional Human Ethics Review Committee, 
and all participants provided signed written consent.   
 
Protocol: All experiments were conducted in the Clinical Cardiovascular Physiology 
Laboratory of the Toronto General Hospital in the morning at a stable temperature 
between 22 and 24°C.  All participants were fasted overnight and avoided exercise, 
alcohol, and caffeine over the 24 hours before the study.  Participants lay in the supine 
position. An antecubital vein was cannulated for blood sampling. Heart rate (HR) was 
determined from lead II of an electrocardiogram recorded continuously throughout the 
study. Arterial BP was measured noninvasively at 1- minute intervals from the left arm 
by an automatic cuff recorder (Dinamap Pro 100, Critikon LLC, Tampa, Fla). A 
respiratory belt encircled the upper abdomen. 
After 10 minutes of quiet supine rest in a semi-dark room, baseline BP and HR 
were acquired during 7 minutes of spontaneous breathing. All participants were then 
exercised on a treadmill for a total of 45 minutes. To provide similar exercise loads, the 
speed and grade of treadmill exercise were adjusted to maintain a target HR recorded 
during exercise at 60% of each individual's peak oxygen consumption (VO2peak), as 
measured during a graded exercise test performed on a separate day.  After exercise, 
participants resumed the resting supine position. Post-exercise measurements commenced 
at 60 minutes after exercise.  In postmenopausal women, this protocol was replicated 4 
weeks after treatment with open-labelled oral estradiol, 2 mg/day. Participants were 
instructed to take this estrogen formulation at approximately the same time each morning, 
with the exception of the study day. After completion of the study protocol, 
postmenopausal women with a uterus in situ were prescribed medroxyprogesterone 
acetate 10-mg tablets once daily for a period of 12 days to convert the endometrium from 
the follicular to the secretory state. 
 
Heart Rate Variability (HRV): Our approach to frequency domain analysis of HRV has 
been previously described 21.  Briefly, during spontaneous breathing, the ECG signal was 
sampled at 1000Hz and was stored using LabView (National Instruments, Austin, TX) 
for subsequent analysis. R-R intervals were analyzed using fast Fourier transformation 
(FFT) to produce a spectral density curve showing a plot of the frequency of the cyclic 
components of variation in the R-R interval duration against the square root of their 
amplitude. A 7-minute data set comprising 2,048 data points was collected and 
subsequently divided into seven segments, each containing 512 points, with one-half 
overlapping of each segment. The linear trend in the data was subtracted from the data set 
in each segment, and a Blackman-Harris window was applied to minimize spectral 
leakage. Power spectra were obtained over a frequency range of 0.0098-0.5 Hz, 
permitting the report of power spectra across very low frequency (VLF) 0.0098-0.05 Hz, 
low frequency (LF: a composite of both sympathetic and parasympathetic modulation), 
0.05-0.15 Hz, and high frequency (HF: an index of parasympathetic modulation), 0.15-
0.5 Hz.  Frequency domains were determined in absolute units (ms2) and with log10 
transformation. For all data sets, only stationary time series with ≤5% arrhythmia or 
artefact were used for analyses.  
 
Peak Aerobic Consumption:  On a separate day, peak oxygen consumption (VO2 peak) 
was measured directly by open-circuit spirometry during a standard graded 
cardiopulmonary exercise stress test.   
   
 
Blood Sampling: Blood was collected from participants at baseline before exercise in 
premenopausal women and in postmenopausal women on both study days. Serum 
concentrations of FSH and 17β-estradiol were analyzed using commercially available 
radioimmunoassay kits (Boehringer, Mannheim, Germany).   
 
Statistical Analysis: All variables are expressed as mean ± standard error of the mean 
(SEM).  All baseline HRV absolute data variables demonstrated a positively skewed 
distribution.  Consequently, VLF, LF and HF were log-transformed (log10) to minimize 
the variance and normalize the distribution.  For postmenopausal women, the average 
values at each phase of the study were compared by 2-factor repeated-measures analysis 
of variance (SPSS version 22.0; SPSS Inc., Chicago, IL) with estrogen and exercise as 
within-subject factors. The Student-Newman-Keuls method was used for pairwise, post 
hoc, multiple comparisons. In premenopausal women, paired t-tests were used to 
compare differences before and after exercise.  The Student t-test was used for unpaired 
observations (premenopausal vs. postmenopausal women). All statistical tests were 2-
tailed with P<0.05 considered the threshold for significance. 
 
RESULTS 
Participants: Baseline physical characteristics of postmenopausal women were: mean age 
54 ± 2 years, body mass index (BMI) 28.6 ± 1.5 kg/m2 and mean VO2peak 1.33 ± 0.01 
L/min 19, 20. For premenopausal women, mean age was 28 ± 1 years, and mean BMI was 
22 ± 1 kg/m2. Mean VO2peak for this group was 1.89 ± 0.02 L/min. These VO2peak 
values were 73% and 85% of predicted, respectively 22.  Each of these characteristics 
were significantly different (P<0.05) between the groups.  
 
Blood Sampling:  As expected, baseline pre-estrogen serum measures of 17 beta-estradiol 
in postmenopausal women were lower (P<0.001) compared with post-estrogen (22 ± 3.3 
vs. 998 ± 220 pmol/L, respectively) 19, 20. FSH (IU/L) was significantly reduced 
(P<0.001) by estrogen therapy (78 ± 3 vs. 37 ± 6, pre- versus post-estrogen, 
respectively).  In the premenopausal group mean serum estradiol measured in the 
follicular phase was 187 ± 28 pmol/L. 
Resting Heart Rate and Arterial Pressure: The BP and HR values of postmenopausal 
women appear in Table 1. With estrogen resting systolic BP was unchanged, but diastolic 
blood pressure (DBP) and mean arterial pressure (MAP) were lower (P< 0.01). Despite 
these changes there were no significant differences between pre–estrogen and post–
estrogen baseline resting values for HR.  Resting HR and BP of premenopausal and 
postmenopausal women were similar (P>0.05). 
Resting HRV: Baseline frequency domain measures of HRV in postmenopausal women 
before and after estrogen are shown in Table 1.  At rest, postmenopausal women 
demonstrated similar LF compared with premenopausal women both pre- and post-
estrogen. In contrast, resting HF were lower (P<0.05) in postmenopausal women both 
before and after estrogen when compared with premenopausal women.   
Exercise:  All participants completed the full 45-minute exercise protocol.  In 
postmenopausal women, heart rates achieved during exercise were 116 ± 4 and 114 ± 3 
beat/min pre–estrogen and post–estrogen, respectively 19, 20. These values corresponded 
to 101% ± 1% and 100% ± 1% of the target exercise HR. Premenopausal women 
achieved mean heart rate of 128±3 beats/min which corresponded to 100±2% of the 
target exercise heart rate. Exercise increased systolic blood pressure (SBP) by 17 ± 3 
mmHg before estrogen as compared with 9 ± 4 mmHg post–estrogen (P=0.12). Exercise 
increased average SBP by 10±4 mmHg in the premenopausal group (P=0.15 
premenopausal vs. postmenopausal pre-estrogen).  
 
After-Exercise Heart Rate and Arterial Pressure: One hour after exercise, in 
postmenopausal women, SBP and DBP were lower (P<0.05) both before and after 
estrogen therapy (Table 1).  One hour after exercise, in premenopausal women, SBP and 
DBP were unchanged (P>0.05). HR post exercise was elevated (P>0.05) and identical in 
the 2 groups 19, 20. 
 
After-Exercise Heart Rate Variability: In postmenopausal women, two-way analysis of 
variance identified that exercise significantly lowered all indices of HRV, except LF/HF, 
which remained unaltered (P>0.05; Table 1).  In contrast, no significant main effect for 
estrogen therapy was detected.  After-exercise, postmenopausal women pre-estrogen 
therapy demonstrated lower (P<0.05) LF, HF and Total HRV compared with 
premenopausal women (Table 1).  Estrogen therapy did not alter (P>0.05) resting or post-
exercise frequency domain measures of HRV.  In premenopausal women, one hour after 
exercise, despite a similar heart rate, all HRV measures were unchanged from pre-
exercise values (P>0.05). 
 
DISCUSSION 
This study had two aims. The first was to compare the after-effects of a single bout of 
dynamic exercise on cardiac autonomic HR modulation assessed by frequency domain 
analysis of HRV in healthy sedentary premenopausal and postmenopausal women. The 
second was to investigate the influence of exogenous estrogen on the post-exercise HRV 
responses in postmenopausal women. Consistent with previous literature 11, 17, 23, 24 HF 
spectral power, an index of parasympathetic modulation of heart rate, was lower at rest in 
postmenopausal compared with premenopausal women. Our key new findings were: 1) in 
healthy sedentary premenopausal women, frequency-domain indexes of heart rate 
modulation recorded one hour post submaximal dynamic exercise were not significantly 
reduced from pre-exercise values. In contrast to these findings in premenopausal women, 
in postmenopausal women; 2) HF and LF remained suppressed below pre-exercise values 
at one hour post acute exercise; and 3) pre-treatment with chronic oral estrogen did not 
augment vagal modulation at rest, or enhance HRV recovery in the post-exercise period, 
suggesting delayed recovery of autonomic modulation. In view of recent concerns that 
these indices of HRV are simply a function of HR 25, it is important to emphasize that 
these differences between premenopausal and postmenopausal women occurred despite 
identical heart rates after exercise. 
The present finding of attenuated HF power, an index of parasympathetic 
modulation of HR, in postmenopausal women at baseline rest when compared with a 
comparator group of premenopausal women is concordant with that of other investigators 
who have shown reductions in HRV in women following both natural 11, 16, 23, 24 and 
surgical 13 menopause.  However, both aging and postmenopausal hormonal deficiency 
may contribute to changes in autonomic heart rate modulation in the postmenopausal 
period. We did not show any significant influence on resting heart rate or augmentation 
of resting HRV in our postmenopausal women following administration of oral estrogen, 
suggesting that the difference in HRV observed between pre- and postmenopausal 
women may be more consistent with aging than estrogen deficiency.  
Previous studies of the effects of exogenous estrogen on resting cardiac 
autonomic heart rate modulation in postmenopausal women have yielded inconsistent 
results.  In some studies, exogenous estrogen has been shown to attenuate, although not 
necessarily fully reverse, menopause-associated decreases in HRV through enhancement 
of cardiac vagal and attenuation of cardiac sympathetic tone 11, 13, 23, 24 whereas other 
studies have been unable to replicate this finding 26, 27.  These inconsistencies may reflect 
differences in subject baseline characteristics, in the type, dose, mode of administration 
and timing of exogenous estrogen and in the experimental condition.  For example, 
Neves et al 24 found that estrogen partially alleviated the decline in HRV in their 
postmenopausal women but only when acquired in the seated but not in the supine 
position. 
Importantly, these previous investigators determined HRV in postmenopausal 
women pre and post-estrogen only under resting conditions. Little is known of the 
influence of exogenous estrogen on HRV following different stimuli known to influence 
autonomic heart rate regulation. For the purpose of this analysis we were particularly 
interested in the after-effects of a single bout of dynamic exercise. Exercise has complex 
effects on sympathovagal heart rate modulation. Regular physical activity is associated 
with increased HRV and in particular a shift towards enhanced parasympathetic 
modulation. These changes are believed to contribute to improved cardiac electrical 
stability, and thus to the well documented cardioprotective benefits of exercise training 9, 
10. However, in contrast to these well recognized cardioprotective effects of regular 
physical activity, risk of sudden cardiac death is increased during and immediately after 
exercise 7, 28.  It is generally agreed that during exercise, there is parasympathetic 
withdrawal and sympathetic excitation 5, 6.  Delayed heart rate recovery in the immediate 
post exercise period is postulated to reflect delayed parasympathetic recovery and has 
been shown to be a predictor of sudden cardiac death. However, data pertaining to the 
kinetics of recovery of autonomic function after cessation of exercise beyond the very 
immediate post-exercise period are much less well explored and the timing and pattern of 
the recovery of autonomic regulation back to baseline is debated 6, 18, 29.   
Of the relatively small number of studies examining the delayed effects of 
exercise on autonomic modulation as measured by HRV, the majority have been 
undertaken in young men. It is unclear whether parasympathetic withdrawal or 
alternatively sympathetic withdrawal predominates in the delayed post-exercise period in 
these studies.  Intensity and type of exercise (e.g. interval vs. constant vs. resistance), 
timing and position of subject during acquisition of recordings post exercise vary 
between these studies and likely contribute to the heterogeneous findings in otherwise 
similar young male cohorts 6, 18, 30-35.   
There is no present published literature concerning HRV responses one hour after 
exercise in either healthy untrained premenopausal or postmenopausal women. Figueroa 
et al compared HRV at 20 minutes post walk exercise at 65% VO2peak in lean (n=8) and 
obese (n=8) middle-aged women (40-60 years) with type 2 diabetes, and 12 obese women 
without type 2 diabetes 36. These investigators reported suppressed HF, more marked in 
the obese and diabetic than lean and diabetic participants post-exercise.  More delayed 
responses post-exercise were not studied, nor were women defined by menopausal status.  
We found no delayed post-exercise effect on HRV in our premenopausal women, but our 
postmenopausal women had persistently depressed HF and Total HRV values at one hour 
after acute submaximal walking exercise. Although we excluded participants with 
glucose intolerance, hyperlipidemia and hypertension, it is possible that the higher BMI 
and lower cardiorespiratory fitness of our postmenopausal women compared to 
premenopausal women contributed to the observed attenuated return of post-exercise HF 
to pre-exercise values.  In support of this concept, previous studies report that elevated 
BMI is inversely and cardiorespiratory fitness positively associated with HRV 37, 38.  
 
Limitations: We did not record HR during controlled breathing, but it has been 
demonstrated previously in middle-aged volunteers studied supine that paced and 
spontaneous breathing provide similar information if recording periods are short and if 
spontaneous breaths fall within the high-frequency band 39 as it was in our participants 
both before and after exercise.  
 
Conclusions: In summary, we have shown that in sedentary premenopausal women HRV 
power spectra density recovers to pre-exercise values when measured an hour after a 
single bout of treadmill exercise performed at a submaximal intensity that is comparable 
to prescriptions recommended for maintenance of cardiovascular health.  In contrast, 
postmenopausal women exhibit significant reductions in HF, LF and total HRV spectral 
power after exercise.  This sustained attenuation, particularly of tonic vagal heart rate 
modulation, is not an artefact of HR, since heart rates after exercise were similar in the 
pre- and postmenopausal women.  Four weeks of estrogen replacement did not increase 
resting HRV and did not accelerate post-exercise HRV recovery in postmenopausal 
women.  These observations suggest aging, and mechanisms consequent to the accretion 
of other age-related changes, such as a high BMI and low cardiorespiratory fitness, 
contribute to the lower resting HRV and delayed HRV recovery one hour post exercise in 
our postmenopausal women.   
Low resting HRV is a recognized marker of adverse prognosis in cardiac patients 
and healthy populations (Tsuji, 1996; Dekker, 2000).  During, and recovery from, 
exercise is suggested to be a vulnerable window for dysrhythmias and fatal events (Lahiri 
2008).  Autonomic evaluation of postmenopausal women during recovery from exercise 
may therefore also be of prognostic importance, particularly in light of current directives 
to actively encourage this population to engage in physical activity as part of a healthy 
lifestyle (Manson 2002; Manson 1999).  Thus, delineation of the additional information 
that could be yielded from post-exercise recovery of HRV in response to both acute and 
chronic exercise training, and how estrogen influences this process, is of significance to 
postmenopausal women. Understanding the short and long-term effects of exercise on the 
cardiac autonomic nervous system will provide insight into whether regular physical 
activity and improved fitness can over time positively influence the post-exercise 
recovery of vagal heart rate modulation of postmenopausal women. 
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Table 1.  Pre- and post-exercise HR, BP and HRV in premenopausal women and healthy 
postmenopausal women pre- and post-estrogen therapy. 
  PreM (n=14)   PMW (n=13)   PMW (n=13) 
 
    
 
Pre Estrogen 
 
Post Estrogen 
  Pre Ex Post Ex   Pre Ex Post Ex   Pre Ex Post Ex 
SBP (mmHg) 101±2 98±2 
 
108±3 103±2a 
 
106±3 99±2a 
DBP (mmHg) 61±2 61±2 
 
64±2 58±2a 
 
60±2b 56±2a 
MAP (mmHg) 74±2 73±2 
 
79±2 73±2a 
 
75±2b 70±2a 
HR (beats/min) 59±2 74±3a 
 
61±3 75±3a 
 
59±2 74±3a 
         LF (log10) 2.88±0.16 2.76±0.15 
 
2.72±0.10 2.08±0.12a,c 
 
2.58±0.13 2.09±0.10a,c  
HF (log10) 3.08±0.16 2.82±0.19 
 
2.64±0.12d 2.11±0.17a,c  
 
2.54±0.12d 2.09±0.12a,c  
VLF (log10) 2.90±0.11 2.86±0.13   2.85±0.12 2.35±0.08a,c   2.74±0.09 2.30±0.11a,c 
All values are mean ± SEM.  
 
DBP, diastolic blood pressure; HF, high frequency power spectra; HR, heart rate; LF, low 
frequency power spectra; log10, log 10 transformed data; MAP, mean arterial pressure; mmHg, 
millimetres of mercury; PMW, postmenopausal women; Pre Ex, pre-exercise; PreM, 
premenopausal women; Post Ex, post-exercise; SBP, systolic blood pressure; VLF, very low 
frequency power spectra. 
 
a P<0.05 vs pre-exercise, within groups 
b P<0.05 vs PMW pre-exercise, pre-estrogen  
c P <0.05 vs PreM post-exercise 
d P <0.05 vs PreM pre-exercise 
 
 
